Forecast: Cardiovascular System Medicine Sales in Australia

Based on the forecasted data:

  • 2024: 11.5%
  • 2025: 11.4%
  • 2026: 11.4%
  • 2027: 11.4%
  • 2028: 11.4%

Year-on-year variations: 2024 to 2025 (-0.87%), 2025 to 2026 (0.00%), 2026 to 2027 (0.00%), 2027 to 2028 (0.00%), resulting in a CAGR over the last 5 years of approximately -0.17%.

Future Trends to Watch

The relatively stable forecast in total sales for cardiovascular system medicines suggests a mature market with stabilized demand. Key trends to monitor include advancements in medical technology, novel drug developments, policy changes in healthcare, and shifts in healthcare infrastructure which could impact market dynamics.

Top Countries about Heart Drug